Abstract
Background
Intracerebral hemorrhage (ICH) constitutes 10% to 15% of all strokes. Despite several existing outcome prediction models for ICH, there are some factors with equivocal value as well as others that still have not been evaluated.
Patients and methods
All patients with first ever supratentorial ICH presenting to our institution between December 1995 and December 2002 were prospectively enrolled into the study. Patients with historic modified Rankin Scale > 2 and those under anticoagulant treatment or with multiple ICH were excluded. The following parameters were analyzed in 194 consecutive patients: age, gender, past history of hypertension, diabetes mellitus, hypercholesterolemia, past history of ischemic stroke, presence of ischemic heart disease or cardioembolic disease, current antiplatelet treatment, current alcohol overuse, smoking, Glasgow Coma Scale score (GSS) at admission, volume and location (deep or lobar) of ICH, ventricular extension, glycemia and temperature at admission, and leukoaraiosis. We correlated these data with the 30–day mortality identifying the independent predictors by logistic regression analysis.
Results
Factors independently associated with 30–day mortality were: age, Glasgow Coma Scale score at admission, ICH volume, ventricular extension, glucose level at admission, and previous antiplatelet use.
Conclusions
Apart from the classical outcome predictors, the previous use of antiplatelet agents and the glucose value at admission are independent predictors of 30–day mortality in patients suffering a supratentorial ICH.
Similar content being viewed by others
References
Arboix A, Massons J, Garcia-Eroles L, Oliveres M, Targa C (2000) Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care 23:1527–1532
Baptista MV, van Melle G, Bogousslavsky J (1999) Prediction of in-hospital mortality after first-ever stroke: the Lausanne Stroke Registry. J Neurol Sci 166:107–114
Berwaerts J, Dijkhuizen RS, Robb OJ, Webster J (2000) Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke 31:2558–2562
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G (1993) Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993
Cheung RT, Zou LY (2003) Use of the Original,Modified, or New Intracerebral Hemorrhage Score to Predict Mortality and Morbidity After Intracerebral Hemorrhage. Stroke 34:1717–1722
Daverat P, Castel JP, Dartigues JF, Orgogozo JM (1991) Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 22:1–6
el Chami B, Milan C, Giroud M, Sautreaux JL, Faivre J (2000) Intracerebral hemorrhage survival: French register data. Neurol Res 22:791–796
Fieschi C, Carolei A, Fiorelli M, Argentino C, Bozzao L, Fazio C, Salvetti M, Bastianello S (1988) Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. Stroke 19:192–195
Fogelholm R, Avikainen S, Murros K (1997) Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28:1396–1400
Franke CL, van Swieten JC, Algra A, van Gijn J (1992) Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry 55:653–657
Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R (1998) Multivariate Analysis of Predictors of Hematoma Enlargement in Spontaneous Intracerebral Hemorrhage. Stroke 29:1160–1166
Hallevy C, Ifergane G, Kordysh E, Herishanu Y (2002) Spontaneous supratentorial intracerebral hemorrhage. Criteria for short-term functional outcome prediction. J Neurol 249:1704–1709
Hardemark HG, Wesslen N, Persson L (1999) Influence of clinical factors, CT findings and early management on outcome in supratentorial intracerebral hemorrhage. Cerebrovasc Dis 9:10–21
He J, Whelton PK, Vu B, Klag MJ (1998) Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 280:1930–1935
Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897
Johnsen SP, Pedersen L, Friis S, Blot WJ, McLaughlin JK, Olsen JH, Sorensen HT (2003) Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based casecontrol study. Stroke 34:387–391
Juvela S (1995) Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 52:1193–1200
Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304–1305
Kronmal RA, Hart RG, Manolio TA, Talbert RL, Beauchamp NJ, Newman A (1998) Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research Group. Stroke 29:887
Kurth T, Kase CS, Berger K, Schaeffner ES, Buring JE, Gaziano JM (2003) Smoking and the risk of hemorrhagic stroke in men. Stroke 34:1151–1155
Lampl Y, Gilad R, Eshel Y, Sarova-Pinhas I (1995) Neurological and functional outcome in patients with supratentorial hemorrhages. A prospective study. Stroke 26:2249–2253
Larrue V, von Kummer RR, Muller A, Bluhmki E (2001) Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European- Australasian Acute Stroke Study (ECASS II). Stroke 32:438–441
Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Torres F, Jimenez MD, Lago A, Melo T; TACIP Investigators (2003) Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind,multicenter trial. Stroke 34:840–848
Neau JP, Couderq C, Ingrand P, Blanchon P, Gil R; VGP Study Group (2001) Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis 11:195–200
Nilsson OG, Lindgren A, Brandt L, Saveland H (2002) Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 97:531–536
Qureshi AI, Safdar K, Weil J, Barch C, Bliwise DL, Colohan AR, Mackay B, Frankel MR (1995) Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 26:1764–1767
Radberg JA, Olsson JE, Radberg CT (1991) Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22:571–576
Rosand J, Hylek EM, O’Donnell HC, Greenberg SM (2000) Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55:947–951
Rosenow F, Hojer C, Meyer-Lohmann C, Hilgers RD, Muhlhofer H, Kleindienst A, Owega A, Koning W, Heiss WD (1997) Spontaneous intracerebral hemorrhage. Prognostic factors in 896 cases. Acta Neurol Scand 96:174–182
Saloheimo P, Juvela S, Hillbom M (2001) Use of aspirin, epistaxis, and untreated hypertension as risk factors for primary intracerebral hemorrhage in middle-aged and elderly people. Stroke 32:399–404
Tatu L, Moulin T, El Mohamad R, Vuillier F, Rumbach L, Czorny A (2000) Primary intracerebral hemorrhages in the Besançon stroke registry. Initial clinical and CT findings, early course and 30-day outcome in 350 patients. Eur Neurol 43:209–214
Terayama Y, Tanahashi N, Fukuuchi Y, Gotoh F (1997) Prognostic value of admission blood pressure in patients with intracerebral hemorrhage. Keio Cooperative Stroke Study. Stroke 28:1185–1188
Tuhrim S, Horowitz DR, Sacher M, Godbold JH (1999) Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27:617–621
Wong KS, Mok V, Lam WWM, Kay R, Tang A, Chan YL, Woo J (2000) Aspirin- associated intracerebral hemorrhage. Clinical and radiologic features. Neurology 54:2298–2301
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roquer, J., Rodríguez Campello, A., Gomis, M. et al. Previous antiplatelet therapy is an independent predictor of 30–day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol 252, 412–416 (2005). https://doi.org/10.1007/s00415-005-0659-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0659-5